Sort   by:  
 Page size 
UnknownTrends in the use of prenatal testing services for fetal aneuploidy in Ontario: a descriptive study.
Not available
S-EPMC6182116 | biostudies-literature
ProteomicsA quantitative proteomics approach to monitor targeted protein degradation in M. smegmatis
Targeted protein degradation via the ubiquitin proteasome has been established in eukaryotes, however no application has been shown in bacteria so far. In the present work, selective protein degradation is shown using hetero bifunctional drugs, bringing substrates in close proximity to the bacterial...
ORGANISM(S): Mycobacterium smegmatis (strain ATCC 700084 / mc(2)155) Bacteria 
2022-08-12 | PXD021505 | Pride
Mycobacteria Targeted protein degradation Protease Tpd 
UnknownCognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial.
Not available
S-EPMC2692580 | biostudies-literature
TranscriptomicsUbiquinol-induced gene expression signatures are translated into reduced erythropoiesis and LDL cholesterol levels in humans
Studies in vitro and in mice indicate a role for Coenzyme Q10 (CoQ10) in gene expression. To determine this function in relationship to physiological readouts, a 2-week supplementation study with the reduced form of CoQ10 (ubiquinol, Q10H2, 150 mg/d) was performed in 53 healthy males. Mean CoQ10 pla...
ORGANISM(S): Homo sapiens 
2013-04-08 | E-GEOD-21351 | biostudies-arrayexpress
UnknownLogarithmically scaled, gamma distributed neuronal spiking.
Not available
S-EPMC10952267 | biostudies-literature
UnknownIdentification of Parkinson's disease PACE subtypes and repurposing treatments through integrative analyses of multimodal data.
Not available
S-EPMC11233682 | biostudies-literature
UnknownPharmacologic rescue of hyperammonemia-induced toxicity in zebrafish by inhibition of ornithine aminotransferase.
Not available
S-EPMC6130883 | biostudies-literature
UnknownComparison of Pimavanserin Versus Quetiapine for Hospitalization and Mortality Risk Among Medicare Beneficiaries with Parkinson's Disease Psychosis.
Not available
S-EPMC10026272 | biostudies-literature
UnknownParkinson’s disease quality of life at 12 months comparing invasive device-aided therapy with oral treatment
Not available
S-EPMC12339671 | biostudies-literature
UnknownAre Parkinson's Patients More Vulnerable to the Effects of Cardiovascular Risk: A Neuroimaging and Neuropsychological Study.
Not available
S-EPMC5729910 | biostudies-literature
Sort   by:  
 Page size